Symbol not found
:ALBO 00:00AM GMT
Market Cap (Intraday) | NA |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | N/A |
50-Day MA | N/A |
200-Day MA | N/A |
Albireo Pharma Inc Stock, :ALBO
53 State Street, 19th Floor, Boston, Massachusetts 02109
United States of America
Phone: +1.857.254.5555
Number of Employees:
Description
Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-G�¶ran Gillberg on December 8, 2003 and is headquartered in Boston, MA.